296 posters, 7 videos, 13 audios, 14 topics, 10 sessions, 1,019 authors, 259 institutions

RCOphth Annual Congress 2026

18 - 21 May, 2026 | Manchester Central, Manchester

Topics

Showing 79 results.

Thumbnail for 12-Month Real-World Clinical and Anatomical Outcomes�With�Faricimab in Patients With�nAMD�or DMO�From�The�Global, Prospective Observational�VOYAGER�Study

P129

12-Month Real-World Clinical and Anatomical Outcomes�With�Faricimab in Patients With�nAMD�or DMO�From�The�Global, Prospective Observational�VOYAGER�Study

Clare Bailey, Steffen Schmitz-Valckenberg, Mariacristina Parravano, Voraporn Chaikitmongkol, Varun Chaudhary, Gloria Chi, Robert Finger, Susumu Ishida, Adrian Koh, Monica Lövestam-Adrian, Jo...

Genentech, Inc., South San Francisco, CA, USA, F. Hoffmann-La Roche Ltd., Basel, Switzerland, Bristol Eye Hospital, University Hospitals Bristol, NHS Foundation Trust, Bristol, UK, John A. Moran Eye Center, Uni...

Poster Presenter: Clare Bailey

Thumbnail for 12-month real-world outcomes of switching to aflibercept 8 mg in suboptimal responders with neovascular Age-Related Macular Degeneration (nARMD)

P130

12-month real-world outcomes of switching to aflibercept 8 mg in suboptimal responders with neovascular Age-Related Macular Degeneration (nARMD)

Georgios Papadakis, Riyaa Sahare, Hamza Mohammed Sultan, Ian De Silva, Rossella Anzidei, Ikenna Ahuche, Urom Chukwunonso, Somain Verma, Vasileios Konidaris

1Medical Retina, Ophthalmology, University Hospitals of Leicester NHS Trust, Leicester UK, 3University of Leicester, Leicester, England, UK, 2Ophthalmology, University Hospitals of Leicester NHS Trust, Leiceste...

Poster Presenter: Georgios Papadakis

Thumbnail for 2-year real-world outcomes�from the use of Faricimab in neovascular�age-related macular degeneration resistant to other anti-vascular endothelial growth factors.

P131

2-year real-world outcomes�from the use of Faricimab in neovascular�age-related macular degeneration resistant to other anti-vascular endothelial growth factors.

Eslam Ahmed, Christine Goodchild, Anastasios Bisoukis, Serena Salvatore

Poster Presenter: Eslam Ahmed

Thumbnail for A Comparative Audit of Faricimab (Vabysmo) versus Aflibercept (Eylea) in the Management of Wet Age-Related Macular Degeneration: Real-World Clinical Outcomes

P132

A Comparative Audit of Faricimab (Vabysmo) versus Aflibercept (Eylea) in the Management of Wet Age-Related Macular Degeneration: Real-World Clinical Outcomes

Oghenemeene Otakoro, Thanura Hewage, Raly Job, Adnan Hafeez, Omara Arshad, Manoj Kulshrestha

Poster Presenter: Oghenemeene Otakoro

Audio

P133

A Novel Ophthalmic Stent Concept to Improve Choroidal Perfusion in Geographic Atrophy: A Proposal for Future Research

Devaki Nayak

null

Poster Presenter: Devaki Nayak

P134

Accelerating the Care Pathway: Faricimab Versus Aflibercept for Discharge and Readmission in Neovascular AMD

Jaskaran Singh Bhangu, Rhadika Rewal, Christopher Stewart, Parinita Swarnkar, Safa Elhassan, Gwyn Williams

null,

Poster Presenter: Jaskaran Singh Bhangu

P135

An Evaluation of Frequency of Rapid Improvement in Glycaemic Control and the Subsequent Effects on Diabetic Retinopathy

Arya Ghatge, Mable Monachan, Andrew Mills, Peter Scanlon

Poster Presenter: Arya Ghatge

P136

Analysis of ABCA4 genotypes in patients with the Arg2107His variant prevalent in those of African ancestry

Abdallah Abbas, Siying Lin, Gavin Arno, Anthony G Robson, Michel Michaelides, Andrew Webster, Omar Mahroo

NIHR Biomedical Research Centre at Moorfields Eye Hospital and the UCL institute of Ophthalmology, London, United Kingdom, NIHR Biomedical Research Centre at Moorfields Eye Hospital and the UCL institute of Oph...

Poster Presenter: Abdallah Abbas

Thumbnail for Anatomical and Functional Effects of Faricimab Intravitreal Injections in Eyes with Macular Oedema Secondary to Retinal Vein Occlusion

P137

Anatomical and Functional Effects of Faricimab Intravitreal Injections in Eyes with Macular Oedema Secondary to Retinal Vein Occlusion

Michael Williams

Poster Presenter: Michael Williams